RichardEldonRoyalMD
General Surgery • Portland, MESurgical Oncology (Other than Breast)
Professor of Surgery, MD Anderson Cancer Ctr., Univ. of Texas
Dr. Royal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
887 Congress St
Portland, ME 04102Phone+1 207-774-6368Fax+1 207-774-9388
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2001 - 2003
University of MarylandResidency, Surgery, 1997 - 2000
University of RochesterFellowship, Surgery, 1994 - 1997
National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 1993 - 1994
Cincinnati Children's Hospital Medical CenterFellowship, Research - Pediatric Surgery, 1991 - 1993
Wellspan Health/York HospitalResidency, Surgery, 1988 - 1991
Oregon Health and Science University School of MedicineClass of 1988
Certifications & Licensure
ME State Medical License 2019 - 2026
OR State Medical License 2019 - 2025
TX State Medical License 2001 - 2021
OH State Medical License 1991 - 2002
PA State Medical License 1990 - 1992- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial Start of enrollment: 2006 Apr 01
- Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer Start of enrollment: 2007 Sep 01
- Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist Start of enrollment: 2010 May 20
- Join now to see all
Publications & Presentations
PubMed
- 13 citationsMalignant Mesothelioma of the Peritoneum in Women: A Clinicopathologic Study of 164 Cases.Anais Malpica, Elizabeth D. Euscher, Mario L. Marques-Piubelli, Maria C. Ferrufino-Schmidt, Roberto N. Miranda
The American Journal of Surgical Pathology. 2021-01-01 - 16 citationsThe Chicago Consensus on peritoneal surface malignancies: Management of desmoplastic small round cell tumor, breast, and gastrointestinal stromal tumorsFrancisco J. Izquierdo, Alejandro Plana, Darryl Schuitevoerder, Andrea Hayes-Jordan, Jeremiah L. Deneve
Cancer. 2020-06-01 - 33 citationsThe Chicago Consensus on peritoneal surface malignancies: Management of colorectal metastasesFrancisco J. Izquierdo, Darryl Schuitevoerder, Alejandro Plana, Oliver S. Eng, Scott K. Sherman
Cancer. 2020-06-01
Journal Articles
- Author Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaJanice N Cormier, Ehab Hanna, Padmanee Sharma, Jennifer A Wargo, Isabella C Glitza, Sapna P Patel, Adi Diab, Jeffrey E Lee, Richard Royal, Randal Weber, Patrick Hwu, J..., Nature
- Publisher Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaScott Woodman, Alexander J Lazar, Michael A Davies, Neil Gross, Sapna P Patel, Isabella C Glitza, Ehab Hanna, Stephen Y Lai, Richard Ehlers, Amy Hessel, Padmanee Sharm..., Nature
- Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaRichard Royal, Alexander J Lazar, Adi Diab, Sapna P Patel, Jeffrey E Lee, Padmanee Sharma, Patrick Hwu, Randal Weber, Jeffrey Gershenwald, Carol Lewis, Richard Ehlers,..., Nature
Press Mentions
Staying Positive in the Face of UncertaintyNovember 30th, 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
